IE73266B1 - Tetrahydrofuran derivatives - Google Patents
Tetrahydrofuran derivativesInfo
- Publication number
- IE73266B1 IE73266B1 IE930472A IE930472A IE73266B1 IE 73266 B1 IE73266 B1 IE 73266B1 IE 930472 A IE930472 A IE 930472A IE 930472 A IE930472 A IE 930472A IE 73266 B1 IE73266 B1 IE 73266B1
- Authority
- IE
- Ireland
- Prior art keywords
- compound
- hydroxy
- phenyl
- tetrahydrofuran
- trans
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D307/10—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D307/14—Radicals substituted by nitrogen atoms not forming part of a nitro radical
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pulmonology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Furan Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB929215274A GB9215274D0 (en) | 1992-07-17 | 1992-07-17 | Derivatives of(phenylethyl-beta-ol)amine |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IE930472A1 IE930472A1 (en) | 1994-01-26 |
| IE73266B1 true IE73266B1 (en) | 1997-05-21 |
Family
ID=10718914
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IE930472A IE73266B1 (en) | 1992-07-17 | 1993-06-24 | Tetrahydrofuran derivatives |
Country Status (32)
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1771435A4 (en) * | 2004-06-19 | 2008-02-13 | Human Biomolecular Res Inst | MODULATORS OF NEUROTRANSMITTERS OF THE CENTRAL NERVOUS SYSTEM |
| WO2020148325A1 (en) | 2019-01-15 | 2020-07-23 | Phenex-Fxr Gmbh | Neutral lxr modulators |
| GB202304652D0 (en) * | 2023-03-29 | 2023-05-10 | Atrogi Ab | New compounds and medical uses thereof |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3700692A (en) | 1971-06-04 | 1972-10-24 | Colgate Palmolive Co | 1-(4{40 -hydroxy-3{40 -(hydroxy methyl)-phenyl)-1-hydroxy-2-aralkylaminoethanes |
| ZW6584A1 (en) * | 1983-04-18 | 1985-04-17 | Glaxo Group Ltd | Phenethanolamine derivatives |
| DE3513885A1 (de) * | 1984-04-17 | 1985-10-17 | Glaxo Group Ltd., London | Phenethanolaminverbindungen, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel |
| DE3731198A1 (de) * | 1987-02-07 | 1988-08-18 | Bayer Ag | 2-aminomethyltetrahydrofurane |
| JPS6485964A (en) * | 1987-03-12 | 1989-03-30 | Glaxo Group Ltd | Compound |
| GB2230525A (en) * | 1989-04-14 | 1990-10-24 | Glaxo Group Ltd | 1-(Hydroxyphenyl)-2-aminoethanol derivatives |
| GB2230775A (en) * | 1989-04-24 | 1990-10-31 | Glaxo Group Ltd | Phenethanolamine compounds |
| NZ235605A (en) * | 1989-10-10 | 1992-12-23 | Glaxo Group Ltd | (r)-(-)-4-hydroxy-alpha 1 -(((6-(4-phenylbutoxy)hexyl)amino)methyl)-1,3-benzenedimethanol and pharmaceutical compositions |
-
1992
- 1992-07-17 GB GB929215274A patent/GB9215274D0/en active Pending
-
1993
- 1993-06-24 IE IE930472A patent/IE73266B1/en not_active IP Right Cessation
- 1993-06-25 GR GR930100276A patent/GR1001565B/el not_active IP Right Cessation
- 1993-06-29 ZA ZA934667A patent/ZA934667B/xx unknown
- 1993-06-29 NO NO932383A patent/NO302946B1/no unknown
- 1993-06-30 IN IN678DE1993 patent/IN183086B/en unknown
- 1993-07-01 NZ NZ248041A patent/NZ248041A/xx unknown
- 1993-07-06 MY MYPI93001317A patent/MY109395A/en unknown
- 1993-07-09 FR FR9308453A patent/FR2693653B1/fr not_active Expired - Fee Related
- 1993-07-09 FR FR9308452A patent/FR2693723B1/fr not_active Expired - Fee Related
- 1993-07-09 CH CH02076/93A patent/CH687705A5/fr not_active IP Right Cessation
- 1993-07-09 BE BE9300712A patent/BE1006429A3/fr not_active IP Right Cessation
- 1993-07-12 DZ DZ930084A patent/DZ1704A1/fr active
- 1993-07-13 CA CA002100381A patent/CA2100381C/en not_active Expired - Fee Related
- 1993-07-13 US US08/091,589 patent/US5447942A/en not_active Expired - Lifetime
- 1993-07-15 PT PT101308A patent/PT101308B/pt not_active IP Right Cessation
- 1993-07-15 LU LU88383A patent/LU88383A1/fr unknown
- 1993-07-15 NL NL9301241A patent/NL9301241A/nl not_active Application Discontinuation
- 1993-07-15 GB GB9314718A patent/GB2268742B/en not_active Expired - Fee Related
- 1993-07-15 PL PL93299693A patent/PL173783B1/pl unknown
- 1993-07-16 SE SE9302437A patent/SE503805C2/sv not_active IP Right Cessation
- 1993-07-16 MA MA23237A patent/MA22937A1/fr unknown
- 1993-07-16 FI FI933235A patent/FI933235A7/fi unknown
- 1993-07-16 DE DE4323976A patent/DE4323976C2/de not_active Expired - Fee Related
- 1993-07-16 TN TNTNSN93081A patent/TNSN93081A1/fr unknown
- 1993-07-16 RU RU9393046412A patent/RU2060252C1/ru active
- 1993-07-16 AU AU42042/93A patent/AU672791B2/en not_active Ceased
- 1993-07-16 ES ES09301603A patent/ES2067417B1/es not_active Expired - Fee Related
- 1993-07-16 HU HU9302057A patent/HUT64757A/hu unknown
- 1993-07-16 OA OA60392A patent/OA09838A/fr unknown
- 1993-07-16 DK DK084793A patent/DK84793A/da not_active Application Discontinuation
- 1993-07-16 JP JP17693293A patent/JP3204811B2/ja not_active Expired - Fee Related
- 1993-07-19 AT AT0142793A patent/AT403693B/de not_active IP Right Cessation
-
1996
- 1996-03-28 HK HK52596A patent/HK52596A/xx not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK143275B (da) | Analogifremgangsmaade til fremstilling af 1-(3-dimethylaminopropyl)-phthalanderivater eller syreadditionssalte deraf | |
| AU2018391657A1 (en) | Enantiomeric separation of racemic nicotine by addition of an O,O'-disubstituted tartaric acid enantiomer | |
| DE69021823T2 (de) | 3-Aryl-Oxazolidinone, Verfahren zu ihrer Herstellung und ihre Anwendung in der Therapie. | |
| DE69709742T2 (de) | Asymmetrische synthese von chiralen beta-aminosäuren | |
| DE3688937T2 (de) | Herstellung optisch aktiver aryloxypropanolamine und arylaethanolamine. | |
| Tanikaga et al. | Stereochemical behavior of intermediary compounds in the amine-catalyzed Knoevenagel reaction. | |
| AU625664B2 (en) | 3,4-Dehydropiperidine derivatives having psychotropic activity | |
| DE69403084T2 (de) | Benzopyrane und diese enthaltende pharmazeutische zusammenstellungen | |
| DE69808068T2 (de) | Verfahren zur herstellung von indolderivaten | |
| IE73266B1 (en) | Tetrahydrofuran derivatives | |
| EP3877372B1 (en) | Enantioselective reduction of oxime-derivatives involving iridium based catalysts | |
| Carter et al. | Analogs of oxybutynin. Synthesis and antimuscarinic and bladder activity of some substituted 7-amino-1-hydroxy-5-heptyn-2-ones and related compounds | |
| IL147668A (en) | Process for the preparation of venlafaxin | |
| US4188341A (en) | Process for the production of (substituted) 2,6-dimethylanilines | |
| DD283616A5 (de) | Verfahren zur herstellung neuer trisubstituierte amine | |
| KR100245981B1 (ko) | 항종양제 내성의 저해 효과를 가지는 화합물, 이의 제조방법 및이를 함유하는 항종양제 내성 저해용 약학적 조성물 | |
| FI77027C (fi) | Saett framstaellning av farmakologiskt verksam 1-/1-(3,4-dimetoxifenyl)-3-amino-propyl/-6,7-dimetoxi- isokinolinfoerening. | |
| JP2899429B2 (ja) | Ｎ−シクロアルキルアルキルアミン、その製造法、薬物としてのその使用、ならびにその合成中間体 | |
| EP0741681B1 (de) | Verfahren zur herstellung von 3-aryl-propinen und neue 3-aryl-propine | |
| DD202710A5 (de) | Verfahren zur herstellung von (thienyl-2)- und (thienyl-3)-2-aethylamin-derivaten | |
| CZ216495A3 (en) | Process for preparing (-)-n-methyl-n-/4-(4-phenyl-4-acetylamino-piperidin-1-yl) -2-(3,4-dichlorophenyl)butyl/benzamide and pharmaceutically acceptable salts thereof | |
| Zee et al. | Stereoselective Synthesis of (+)‐Peperomin C | |
| FR2663025A1 (fr) | Derives de 2-aminomethylpyrrolidine, leur preparation et leur application en therapeutique. | |
| WO1998055478A1 (fr) | Nouveaux derives de phencyclidines, des procedes pour leur preparation et des compositions pharmaceutiques les contenant | |
| JPS6115077B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | Patent lapsed |